KuartisMED

About:

KuartisMED is a biomedical company developing products for the well-being of preterm infants.

Website: http://kuartismed.com/

Twitter/X: KuartisMED

Top Investors: EASME - EU Executive Agency for SMEs, APY Ventures, Turkey Development Fund, Arya Women's Investment Platform, Teknoloji Yatirim

Description:

KuartisMED is a biomedical company developing products for the well-being of preterm infants. It developed Premades, a monitoring feeding ability for newborns. KuartisMED is a proud Horizon 2020 SME Instrument grantee. Its banner product has received a Phase-2 grant for the “SMEInst-12-2016-2017 — New business models for inclusive, innovative and reflective societies” which is awarded from the European Union’s Horizon 2020 research and innovation program. The company had previously received H2020 SME Instrument Phase-1 grant in 2014 for the Feasibility Study and Commercialization Plan for PREMADES.

Total Funding Amount:

$3.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ankara, Ankara, Turkey

Founded Date:

2014-01-01

Contact Email:

info(AT)kuartismed.com

Founders:

Ahmet Saracoglu

Number of Employees:

1-10

Last Funding Date:

2022-11-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai